Exploiting the Antidiabetic and Anti Obesity Properties of Incretins and Their Analogues

来源 :中国上海第七届国际新药发明科技年会 | 被引量 : 0次 | 上传用户:hqc12322967
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Type 2 diabetes mellitus is associated with progressive decreases in pancreatic 8-cell function.Most patients thus require increasingly intensive treatment,including oral combination therapies followed by insulin.Fear of hypoglycemia and weight gain is a potential barrier to treatment adherence and glycemic control,while weight gain can exacerbate hyperglycemia or insulin resistance.Administration of insulin can roughly mimic physiologic insulin secretion but does not address underlying pathophysiology.Glucagon-like peptide 1 (GLP-1) is an incretin hormone released by the gut in response to meals that helps to maintain glucose homeostasis through coordinated effects on islet α-and B-cells,inhibiting glucagon output,and stimulating insulin secretion in a glucose-dependent manner.Biological effects of GLP-1 include slowing gastric emptying and decreasing appetite.
其他文献
1.Nutritional concepts for treatment of chronic inflammatory diseases.Inflammation is defined as one of the first responses of the immune system to injury.When the injury is not eliminated,resolution
会议
Multi-drug resistant (MDR) bacteria present a significant,global healthcare problem that is amplified by the lack of new antibiotics,especially against MDR gram-negative pathogens.We developed new pha
会议
Tuberculosis is today amongst the worldwide health threats.As resistant strains of Mycobacterium tuberculosis have slowly emerged,treatment failure is too often a fact.Discovery of new efficient drug
会议
Bimodal relapse patterns have now been identified in 13 independent breast cancer databases from the US,Europe and Asia.As my colleagues and I have reported,interpretation of this pattern strongly sug
会议
Objectives:Anticancer therapies with vascular disrupting agents (VDAs) or radiofrequency ablation (RFA) can noninvasively or minimum-invasively induce tumor necrosis but often leave viable residues le
会议
Diabetes mellitus is a chronic disease which is estimated to affect more than 171 million people worldwide.Despite the recent clinical success of GLP-1 and DPP4-based treatments,the unmet medical need
会议
Context and Objective:Thiazolidinediones (TZDs) inhibit estrogen production in ovarian cells.We explored whether TZDs affect aromatase activity.Materials & Methods:Human granulosa cells were incubated
会议
1.Discovery of a new drug that treat insulin resistance,which is not a simple blood glucose lowering drug:We have discovered that Cyclo (his-pro) (CHP),a thyrotropin releasing hormone metabolite,stimu
会议
This lecture will discuss the role of three mechanisms i.e.,poly(ADP-ribose) polymerase (PARP),12/15-1ipoxygenase (LO),and Na+/H+-exchanger-1 (NHE-1),in peripheral diabetic neuropathy (PDN).PARP catal
会议
To keep blood glucose in normal level without stimulation of insulin Secretion is the effective therapy for diabetes owing to reduction of the burden for ?-cells.We found a novel diabetes-therapy base
会议